methylmalonic acid has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Methylmalonic Acid: A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.
methylmalonic acid : A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabresi, P | 1 |
| Gubellini, P | 1 |
| Picconi, B | 1 |
| Centonze, D | 1 |
| Pisani, A | 1 |
| Bonsi, P | 1 |
| Greengard, P | 1 |
| Hipskind, RA | 1 |
| Borrelli, E | 1 |
| Bernardi, G | 1 |
1 other study available for methylmalonic acid and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine.
Topics: Animals; Calcium Channel Blockers; Chelating Agents; Corpus Striatum; Dopamine; Electric Stimulation | 2001 |